Shamburg News · 8-K filed Nov 17, 2026, 4:05 PM EST

Inovio Pharmaceuticals Expands Board to Nine and Appoints Jeffrey Libson as Director

INO · INOVIO PHARMACEUTICALS, INC.

  • Leadership change
  • Materiality: medium

Effective November 13, 2026, Inovio Pharmaceuticals increased its Board from eight to nine directors and appointed Jeffrey Libson to the newly created seat. Libson was also appointed to the Finance Committee and will receive a $45,000 annual Board cash retainer and a $5,000 annual Finance Committee retainer under the non-employee director compensation program. He will hold office until the 2027 annual meeting and will enter into the company's standard indemnification agreement.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001193125-26-465502.

Written from the filing by Shamburg Markets. Figures are as reported by the company.